137 related articles for article (PubMed ID: 17632268)
1. Amyloid-beta and synaptic activity in mice and men.
Ihara M; Kalaria RN
Neuroreport; 2007 Aug; 18(12):1205-6. PubMed ID: 17632268
[No Abstract] [Full Text] [Related]
2. Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25-35) are dependent on stimulation-protocol and genetic background.
Gengler S; Gault VA; Harriott P; Hölscher C
Exp Brain Res; 2007 Jun; 179(4):621-30. PubMed ID: 17171334
[TBL] [Abstract][Full Text] [Related]
3. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).
Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E
J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377
[TBL] [Abstract][Full Text] [Related]
4. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice.
Wirths O; Multhaup G; Czech C; Blanchard V; Moussaoui S; Tremp G; Pradier L; Beyreuther K; Bayer TA
Neurosci Lett; 2001 Jun; 306(1-2):116-20. PubMed ID: 11403971
[TBL] [Abstract][Full Text] [Related]
5. Genetic ablation of luteinizing hormone receptor improves the amyloid pathology in a mouse model of Alzheimer disease.
Lin J; Li X; Yuan F; Lin L; Cook CL; Rao ChV; Lei Z
J Neuropathol Exp Neurol; 2010 Mar; 69(3):253-61. PubMed ID: 20142765
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice.
Wang J; Tanila H; Puoliväli J; Kadish I; van Groen T
Neurobiol Dis; 2003 Dec; 14(3):318-27. PubMed ID: 14678749
[TBL] [Abstract][Full Text] [Related]
7. Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains.
Gonzalez-Castro R; Acero Galindo G; García Salcedo Y; Uribe Campero L; Vazquez Perez V; Carrillo-Tripp M; Gevorkian G; Gomez Lim MA
Inflammopharmacology; 2018 Jun; 26(3):817-827. PubMed ID: 29094307
[TBL] [Abstract][Full Text] [Related]
8. Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice.
Gordon MN; King DL; Diamond DM; Jantzen PT; Boyett KV; Hope CE; Hatcher JM; DiCarlo G; Gottschall WP; Morgan D; Arendash GW
Neurobiol Aging; 2001; 22(3):377-85. PubMed ID: 11378242
[TBL] [Abstract][Full Text] [Related]
9. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice.
Dewachter I; Reversé D; Caluwaerts N; Ris L; Kuipéri C; Van den Haute C; Spittaels K; Umans L; Serneels L; Thiry E; Moechars D; Mercken M; Godaux E; Van Leuven F
J Neurosci; 2002 May; 22(9):3445-53. PubMed ID: 11978821
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain.
Bürger S; Noack M; Kirazov LP; Kirazov EP; Naydenov CL; Kouznetsova E; Yafai Y; Schliebs R
Int J Dev Neurosci; 2009 Oct; 27(6):517-23. PubMed ID: 19589380
[TBL] [Abstract][Full Text] [Related]
11. Prion infection of mice transgenic for human APPSwe: increased accumulation of cortical formic acid extractable Abeta(1-42) and rapid scrapie disease development.
Baier M; Apelt J; Riemer C; Gültner S; Schwarz A; Bamme T; Burwinkel M; Schliebs R
Int J Dev Neurosci; 2008 Nov; 26(7):821-4. PubMed ID: 18662767
[TBL] [Abstract][Full Text] [Related]
12. Ablating ErbB4 in PV neurons attenuates synaptic and cognitive deficits in an animal model of Alzheimer's disease.
Zhang H; Zhang L; Zhou D; He X; Wang D; Pan H; Zhang X; Mei Y; Qian Q; Zheng T; Jones FE; Sun B
Neurobiol Dis; 2017 Oct; 106():171-180. PubMed ID: 28684271
[TBL] [Abstract][Full Text] [Related]
13. [The role of Alzheimer amyloid plaques in the mechanisms of neuron synaptic plasticity disturbance].
Berezov TT; Kudinova NV; Kudinov AP
Vestn Ross Akad Med Nauk; 2005; (10):3-7. PubMed ID: 16320698
[TBL] [Abstract][Full Text] [Related]
14. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.
Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T
Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835
[TBL] [Abstract][Full Text] [Related]
15. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice.
Kimura R; Devi L; Ohno M
J Neurochem; 2010 Apr; 113(1):248-61. PubMed ID: 20089133
[TBL] [Abstract][Full Text] [Related]
16. Selective nicotinic receptor consequences in APP(SWE) transgenic mice.
Bednar I; Paterson D; Marutle A; Pham TM; Svedberg M; Hellström-Lindahl E; Mousavi M; Court J; Morris C; Perry E; Mohammed A; Zhang X; Nordberg A
Mol Cell Neurosci; 2002 Jun; 20(2):354-65. PubMed ID: 12093166
[TBL] [Abstract][Full Text] [Related]
17. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
[TBL] [Abstract][Full Text] [Related]
18. Transgenic animals in Alzheimer's disease research.
Sturchler-Pierrat C; Sommer B
Rev Neurosci; 1999; 10(1):15-24. PubMed ID: 10356989
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-beta: a (life) preserver for the brain.
Obrenovich ME; Joseph JA; Atwood CS; Perry G; Smith MA
Neurobiol Aging; 2002; 23(6):1097-9. PubMed ID: 12470809
[No Abstract] [Full Text] [Related]
20. Probiotic treatment improves the impaired spatial cognitive performance and restores synaptic plasticity in an animal model of Alzheimer's disease.
Rezaei Asl Z; Sepehri G; Salami M
Behav Brain Res; 2019 Dec; 376():112183. PubMed ID: 31472194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]